제품
No. |
Product Name |
CAS No. |
406 |
Cloxacillin Sodium |
642-78-4 |
407 |
Pyridostigmine bromide |
101-26-8 |
408 |
2-(5-chloro-2-phenoxyphenyl)acetic acid |
70958-20-2 |
409 |
Coenzyme a |
85-61-0 |
410 |
Pyridoxal HCL |
65-22-5 |
411 |
2-Methoxy-pyridine-3-carbaldehyde |
71255-09-9 |
412 |
Colchicine |
64-86-8 |
413 |
Pyridoxine HCL |
58-56-0 |
414 |
1,2,4-Triazolo[4,3-a]pyridine, 5,6,7,8-tetrahydro-3-[2-[4-(2-methylphenyl)- 1-piperazinyl]ethyl] |
72822-12-9 |
415 |
Combretastatin A-4 |
117048-59-6 |
416 |
Pyrimethamine |
58-14-0 |
417 |
7,8-Dimethoxy-1,3-dihydro-2H-3-Benzazepin-2-one |
73942-87-7 |
418 |
Conjugated Estrogens |
12126-59-9 |
419 |
Posaconazole |
171228-49-2 |
420 |
1-Boc-3-Oxopiperazine,4-N-Boc-2-Oxo-Piperazine |
76003-29-7 |
421 |
Cortisone acetate |
50-04-4 |
422 |
5-bromo-3-methylbenzene-1,2-diamine |
76153-06-5 |
423 |
Cosyntropin |
16960-16-0 |
424 |
1-Amino-2-(isopropylsulphonyl) benzene |
76697-50-2 |
425 |
Crotamiton |
483-63-6 |
426 |
4-bromo-3-nitrophenol |
78137-76-5 |
427 |
Cycloheximide |
66-81-9 |
428 |
Pneumocandin B0 |
135575-42-7 |
429 |
CYCLOHEXYLMETHYL BROMIDE |
2550-36-9 |
430 |
Terephthaldehyde monodiethylacetal |
81172-89-6 |
431 |
Cyclopentolate Hcl |
5870-29-1 |
432 |
3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one |
85175-59-3 |
433 |
Cyclophosphamide |
6055-19-2 |
434 |
4-bromo-2,5-dimethylphenol |
85223-93-4 |
435 |
Cyclosporine |
59865-13-3 |
436 |
4-hydroxy-2,5-dimethylbenzaldehyde |
85231-15-8 |
437 |
Cyproterone acetate |
427-51-0 |
438 |
7-Ethyl-10-Hydroxycamptothecin |
86639-52-3 |
439 |
Cytarabine |
147-94-4 |
440 |
Cytarabine hydrochloride |
69-74-9 |
441 |
3-(1-Piperazinyl)-1,2-benzisothiazolez |
87691-87-0 |
442 |
6-Methoxy-N-methylpyridin-2-amine |
88569-83-9 |
443 |
2-Azetidineacetic acid, 3-[(1R)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl] -a-methyl-4-oxo-, (aR,2S,3S)- |
90776-58-2 |
444 |
3-Fluoro-4-morpholinoaniline |
93246-53-8 |
445 |
8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione |
93703-24-3 |
.Remark: products patented are for R&D only and are permitted under 35 USC 271(e).
.Patent products cannot be offered to the countries where patent law is in force.
Final responsibility lies with the buyer exclusively.